Login / Signup

Antibiotic stewardship: Early discontinuation of antibiotics based on procalcitonin level in COVID-19 pneumonia.

Archana RoyHarry Ross PowersEmily C CraverMark D NazarenoSiva Naga S YarrarapuDevang K Sanghavi
Published in: Journal of clinical pharmacy and therapeutics (2021)
Procalcitonin level remains low in the absence of bacterial infection. Early de-escalation/discontinuation of antibiotics is safe without adverse outcomes in COVID-19 pneumonia. Early de-escalation/discontinuation of antibiotics is associated with lower LOS.
Keyphrases
  • coronavirus disease
  • sars cov
  • open label
  • intensive care unit
  • respiratory syndrome coronavirus
  • study protocol
  • community acquired pneumonia